cancer-immunotherapy

Documents about cancer-immunotherapy

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)#321696ClinicalTrials.gov
• A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy#325291ClinicalTrials.gov
• Circadian rhythms and lung cancer biology and immunotherapy: Emerging opportunities and challenges.#338425NCBI PubMed Central
• Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting.#340426NCBI PubMed Central
• IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy#343834ClinicalTrials.gov
• Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer.#380882NCBI PubMed Central
• Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma#383569ClinicalTrials.gov
• Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma#463705ClinicalTrials.gov
• Spatial immune niches in gastric cancer immunotherapy resistance: mechanisms and translational implications.#465189NCBI PubMed Central
• An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC#668822ClinicalTrials.gov
• CAR- PRISM (PRecision Intervention Smoldering Myeloma)#840976ClinicalTrials.gov
• Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma#813762ClinicalTrials.gov
• Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.#868940ClinicalTrials.gov
• Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)#442075ClinicalTrials.gov
• Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026#472091IRIS
• A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer#855419ClinicalTrials.gov
• Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy#121372ClinicalTrials.gov
• Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion#234422ClinicalTrials.gov
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer#256875ClinicalTrials.gov
• Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours#299165Springer Nature OA
• Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients#867723ClinicalTrials.gov
• A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors#858358ClinicalTrials.gov
• Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer#683072ClinicalTrials.gov
• Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma#4717Europe PMC
• Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer#807820ClinicalTrials.gov
• Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)#136309ClinicalTrials.gov
• A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy#366598ClinicalTrials.gov
• VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer#460079ClinicalTrials.gov
• GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma#67857ClinicalTrials.gov
• Development and Validation of a Predictive Model for Immunotherapy Benefit in Extensive-Stage Small Cell Lung Cancer.#122177DataCite
• Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab#126722HAL (France)
• Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma#127571ClinicalTrials.gov
• Pilot Immunotherapy Trial for Recurrent Malignant Gliomas#154638ClinicalTrials.gov
• Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC#160342ClinicalTrials.gov
• Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy#160350ClinicalTrials.gov
• Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC#160372ClinicalTrials.gov
• Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer#184849ClinicalTrials.gov
• Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease#261494ClinicalTrials.gov
• Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer#377413ClinicalTrials.gov
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery#383568ClinicalTrials.gov
• Predictive biomarkers for immunotherapy response in endometrial cancer: current insights and future directions.#399653NCBI PubMed Central
• Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy#414479ClinicalTrials.gov
• Editorial: Integrating molecular mechanisms, immunotherapy, and drug sensitivity in cancer immunology and oncology.#433853NCBI PubMed Central
• Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.#446238NCBI PubMed Central
• From T cell engagers to next-generation immune cell engagers for cancer immunotherapy.#452905NCBI PubMed Central
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma#454030ClinicalTrials.gov
• Circulating tumor DNA in lung cancer immunotherapy: prognostic marker today, predictive tool tomorrow?#653410NCBI PubMed Central
• Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer#811412ClinicalTrials.gov
• A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer#18602ClinicalTrials.gov
• Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors#311119ClinicalTrials.gov